News New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance Continue Reading Previous New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral ClearanceNext Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Related Stories News Appalachian Wireless Among First Regional Carriers to Launch RCS for Business with ClearSky News Saviynt Launches EU Identity Security Offering on French S3NS’s Trusted Cloud News Astra Security Connects Autonomous Pentesting to Claude Code and GitHub Copilot Through New MCP Server News G6 Hospitality’s North American Portfolio Grows to Over 1,600 Hotels News DTEX Introduces Precision Tuner for Continuous AI Security Optimization News Splashtop Joins Microsoft Virus Initiative, Strengthening Protection for Microsoft Environments